M
Michael R. Green
Researcher at University of Texas MD Anderson Cancer Center
Publications - 597
Citations - 65007
Michael R. Green is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: RNA splicing & RNA. The author has an hindex of 126, co-authored 537 publications receiving 57447 citations. Previous affiliations of Michael R. Green include Eppley Institute for Research in Cancer and Allied Diseases & United States University.
Papers
More filters
Journal ArticleDOI
Identifying Mechanisms of Glucocorticoid Resistance in Relapsed Pediatric T-ALL
Justine E. Roderick,Kayleigh M Gallagher,Katherine M Tang,Olivia Kugler-Umana,Lihua Julie Zhu,Michael R. Green,Michelle A. Kelliher +6 more
TL;DR: It is predicted that targeting these dexamethasone resistance pathways may re-sensitize relapse pediatric T-ALL cells to dexamETHasone and/or contribute to more effective patient stratification to prevent relapse and induction failure.
Book ChapterDOI
HTLV-I Tax
Giovanni Perini,Michael R. Green +1 more
TL;DR: Human T-cell Leukemia Virus type I (HTLV-I) is a human retrovirus that causes disease mainly in the Mediterranean and south tropical areas and can also cause a severe granulocytosis and eosinophilia and in some cases an autoimmune chronic athritis.
Journal ArticleDOI
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma
Johannes F. Fahrmann,Neeraj Saini,Chang Chia-Chi,Ehsan Irajizad,Paolo Strati,Ranjit Nair,Louis Fayard,Saira Ahmed,Hun Ju Lee,K. Swaminathan Iyer,Raphael E Steiner,Jody Vykoukal,Ranran Wu,Jennifer B. Dennison,Loretta J. Nastoupil,Preetesh Jain,Michael Wang,Michael R. Green,Jason R. Westin,Viktoria Blumenberg,Marco L. Davila,Richard E. Champlin,Elizabeth J. Shpall,Partow Kebriaei,Christopher R. Flowers,Michael D. Jain,Robert R. Jenq,Christoph K. Stein-Thoeringer,Marion Subklewe,Sattva S. Neelapu,Samir M. Hanash +30 more
TL;DR: In this paper , an anti-CD19 chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory (r/r) large B cell lymphoma (LBCL) results in durable response in only a subset of patients.
Journal ArticleDOI
Activated B cells suppress T-cell function through metabolic competition
Nobuhiko Imahashi,Rafet Basar,Yuefan Huang,Fang Wang,Natalia Baran,Pinaki P. Banerjee,Junjun Lu,Ana Karen Nunez Cortes,Nadima Uprety,Emily Ensley,Luis Muniz-Feliciano,Tamara Laskowski,Judy S. Moyes,May Daher,Mayela Mendt,Lucila Nassif Kerbauy,Mayra Shanley,Li Li,Francesca Lorraine Wei Inng Lim,Hila Shaim,Ye E. Li,Marina Konopleva,Michael R. Green,Jennifer A. Wargo,Elizabeth J. Shpall,Kenneth S. Chen,Katayoun Rezvani +26 more
TL;DR: In this paper , the authors investigated the potential contribution of metabolic activity of activated B cells to T-cell suppression by performing in vitro experiments and by analyzing clinical samples using mass cytometry and single-cell RNA sequencing.
Journal ArticleDOI
Measurement of Radioactivity in Nucleic Acids.
Michael R. Green,Joseph Sambrook +1 more
TL;DR: Radioactive isotopes are used as tracers to monitor the progress of many reactions used to synthesize DNA and RNA and an effective method is differential precipitation of the nucleic acid products with trichloroacetic acid (TCA).